DEMEGEN INC
10KSB40, EX-27, 2000-12-15
MEDICAL LABORATORIES
Previous: DEMEGEN INC, 10KSB40, EX-24, 2000-12-15
Next: CELLOMICS INC, S-1/A, 2000-12-15



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM AUDITED
BALANCE SHEET AT SEPTEMBER 30, 2000 AND STATEMENT OF OPERATIONS FOR THE YEAR
ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               SEP-30-2000
<CASH>                                       1,825,352
<SECURITIES>                                         0
<RECEIVABLES>                                   22,409
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,847,761
<PP&E>                                         365,801
<DEPRECIATION>                                 208,971
<TOTAL-ASSETS>                               2,311,592
<CURRENT-LIABILITIES>                          434,353
<BONDS>                                        360,180
                                0
                                  2,033,787
<COMMON>                                        32,305
<OTHER-SE>                                   (666,294)
<TOTAL-LIABILITY-AND-EQUITY>                 2,311,592
<SALES>                                              0
<TOTAL-REVENUES>                               763,765
<CGS>                                                0
<TOTAL-COSTS>                                2,419,247
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,655,482)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,655,482)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,655,482)
<EPS-BASIC>                                     (0.06)
<EPS-DILUTED>                                   (0.06)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission